ZIVO Bioscience Inc. (ZIVO)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

Company Description

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers.

The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.

Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging.

The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014.

ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

ZIVO Bioscience Inc.
ZIVO Bioscience Inc. logo
Country United States
IPO Date Dec 15, 2003
Industry Biotechnology
Sector Healthcare
Employees 8
CEO John B. Payne

Contact Details

Address:
21 East Long Lake Road
Bloomfield Hills, Michigan
United States
Website https://www.zivobioscience.com

Stock Details

Ticker Symbol ZIVO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001101026
CUSIP Number 98978N200
ISIN Number US98978N2009
Employer ID 87-0699977
SIC Code 2836

Key Executives

Name Position
John B. Payne President, Chief Executive Officer & Chairman of the Board
Keith R. Marchiando Chief Financial Officer, Treasurer & Secretary
Dr. Harlan L. Miller III Vice President of Technology & Global Supply

Latest SEC Filings

Date Type Title
Nov 15, 2024 8-K Current Report
Nov 14, 2024 10-Q Quarterly Report
Oct 18, 2024 8-K Current Report
Oct 17, 2024 4 Filing
Oct 16, 2024 4 Filing
Oct 01, 2024 3 Filing
Oct 01, 2024 SC 13D/A [Amend] Filing
Aug 23, 2024 4 Filing
Aug 23, 2024 4 Filing
Aug 14, 2024 10-Q Quarterly Report